// App-Quantinova.ai

2507 : Low Levels of Mir-151-5p and Mir-451 Predict Relapse in Pediatric B-Lineage Acute Lymphoblastic Leukemia.

Researchers

Presenter

  • Iedan RN Verly

Principal Investigators

  • Gertjan J.L. Kaspers

  • Dafna Gaash

  • Marta Jeison

  • Galia Avrahami

  • Sarah Elitzur

  • Gil Gilad

  • Batia Stark

  • Isaac Yaniv

  • Jacqueline Cloos

  • Anat Ohali

  • Michal Hameiri-Grossman

  • Eva Fonkova

  • Jan Trka

  • Drorit Luria

  • Yona Kodman

  • Hadar Mirsky

Medical Centers

  • Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah-Tikva, Israel

  • Pediatric Hematology Oncology, VU University Medical Center, Amsterdam, Netherlands

  • Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands

  • Pediatric Hematology/Oncology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic

  • Molecular Oncology, Felsenstein Medical Research Center, Petah-Tikva, Israel,

Locations

  • Czech Republic

  • Netherlands

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved